IL6 and nosocomial infection: IL-6 is considered a reliable marker of illness severity, and monocytes express HLA-DR molecules, which are responsible for antigen presentation to T cells and are a validated marker of immune function associated with the risk of nosocomial infection acquisition and mortality in critically ill patients [36, 37].